About RX CJC-1295

What this site is

RX CJC-1295 is an independent editorial project that publishes summaries of the peer-reviewed research literature on CJC-1295. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The approach is deliberately narrow: read the published record, log each measured datum to its study, and mark the points where the evidence stops. The compound's profile is a tight envelope of early human pharmacokinetic data wrapped around an engineered long-acting design, and a clinical program that did not advance. We treat that as a flight log — a record of what the telemetry shows and where the readout goes dark — rather than a set of claims to promote.

What the 'RX' in the name means

The "RX" in RX CJC-1295 is editorial framing — a mission call-sign and log designator, the posture this publisher takes toward the literature. It is not a claim about services. This site is not a pharmacy and dispenses nothing; it does not offer treatment, consultation, or prescription. The prefix marks a register — a precise, record-keeping read of the science — not a counter.

How we cite

Every quantitative claim on this site — every half-life, dose, fold-change, and duration — resolves to a numbered source in the full reference list. Where a finding is a measured human or animal result, it is logged as such; where a statement is a regulatory fact or an open question, it is flagged as such. We use only generic compound and drug-class names. We describe what was administered to which species at which dose by which route, and we do not translate that into directions for use.

What we do not claim

We do not claim that CJC-1295 is safe, effective, or appropriate for any human use. CJC-1295 is unapproved for human use anywhere and is prohibited at all times in sport under WADA Section S2 ^[1]. We do not name any commercial product, and we do not link to other sites in our publishing network. The record speaks in measured numbers and flagged gaps; we keep our commentary to reading it accurately.

Why the flight-log register

We chose the mission-log framing because it fits the evidence. CJC-1295's record divides cleanly into two kinds of line: telemetry that was actually measured — the 5.8-8.1-day half-life, the GH and IGF-1 kinetics, the preserved pulsatility, the rat bioconjugate AUC ^[1][2][3] — and status flags where the readout goes dark: the scrubbed Phase 2 program, the absent efficacy trials, the regulatory non-recommendation, the anti-doping prohibition ^[1][7]. A register that distinguishes a confirmed reading from a critical gap is the honest way to present a compound whose pharmacology is well-characterized but whose clinical case is unmade. We do not soften the gaps and we do not inflate the readings; both are part of the same log.